J2778 Ranibizumab injection
J-Codes
Also known as: ranibizumab, lucentis, susvimo
Injection of ranibizumab (Lucentis, Susvimo), a recombinant humanized monoclonal antibody fragment against vascular endothelial growth factor A (VEGF-A) for retinal diseases.
Clinical Context
Administered by intravitreal injection for age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.